15821460

Source:http://linkedlifedata.com/resource/pubmed/id/15821460

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001758, umls-concept:C0030705, umls-concept:C0138741, umls-concept:C0181904, umls-concept:C0229671, umls-concept:C0376358, umls-concept:C0430420, umls-concept:C0449295, umls-concept:C0596972, umls-concept:C0728873, umls-concept:C1521743, umls-concept:C1524063, umls-concept:C1704646
pubmed:issue	5
pubmed:dateCreated	2005-4-11
pubmed:abstractText	We reviewed the literature to help clarify the benefits and/or hazards associated with monitoring serum prostate specific antigen (PSA) after treatment with surgery or radiation therapy (RT) for nonmetastatic prostate cancer.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0376374
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Prostate-Specific Antigen
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	0022-5347
pubmed:author	pubmed-author:AbnerAnthonyA, pubmed-author:HorwitzEricE, pubmed-author:KestinLarryL, pubmed-author:MartinezAlvaroA, pubmed-author:VargasCarlosC, pubmed-author:ViciniFrank AFA
pubmed:issnType	Print
pubmed:volume	173
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1456-62
pubmed:meshHeading	pubmed-meshheading:15821460-Humans, pubmed-meshheading:15821460-Male, pubmed-meshheading:15821460-Prostate-Specific Antigen, pubmed-meshheading:15821460-Prostatic Neoplasms
pubmed:year	2005
pubmed:articleTitle	Limitations in the use of serum prostate specific antigen levels to monitor patients after treatment for prostate cancer.
pubmed:affiliation	Departments of Radiation Oncology, William Beaumont Hospital, Royal Oak, Michigan 48073, USA. fvicini@beaumont.edu
pubmed:publicationType	Journal Article, Review